Regeneron (REGN) analyst forecast and price target
Analyst forecast
Consensus of 30 analyst ratings
Based on 11 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Leerink Partners | Maintained | Market Perform | $824.00 from $641.00 | Aug 17, 2026 |
| Guggenheim | Maintained | Buy | $1,030.00 from $1,000.00 | Aug 3, 2026 |
| Citigroup | Maintained | Neutral | $740.00 from $700.00 | Aug 3, 2026 |
| Truist Securities | Maintained | Buy | $772.00 from $769.00 | Jul 31, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $750.00 from $700.00 | Jul 31, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $795.00 from $750.00 | Jul 31, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $758.00 from $730.00 | Jul 31, 2026 |
| RBC Capital | Maintained | Sector Perform | $737.00 from $696.00 | Jul 31, 2026 |
| Guggenheim | Maintained | Buy | $1,000.00 from $995.00 | Jul 21, 2026 |
| Piper Sandler | Maintained | Overweight | $854.00 from $855.00 | Jul 9, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $730.00 from $788.00 | Jul 8, 2026 |
| Benchmark | Upgraded | Hold → Buy | $185.00 | Jul 7, 2026 |
| Truist Securities | Maintained | Buy | $769.00 from $778.00 | Jul 7, 2026 |
| RBC Capital | Maintained | Sector Perform | $696.00 from $707.00 | Jul 7, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $750.00 from $785.00 | Jul 6, 2026 |
| HSBC | Maintained | Buy | $880.00 from $990.00 | Jul 6, 2026 |
| Canaccord Genuity | Maintained | Buy | $875.00 from $1,057.00 | May 19, 2026 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $641.00 from $792.00 | May 18, 2026 |
| Citigroup | Downgraded | Buy → Neutral | $700.00 from $900.00 | May 18, 2026 |
| RBC Capital | Maintained | Sector Perform | $707.00 from $762.00 | May 18, 2026 |
Frequently asked questions
What is the price target for REGN stock?
The average 12-month analyst price target for Regeneron (REGN) is $756.82, with a high estimate of $1,030.00 and a low of $185.00, across 11 analysts.
Is REGN a buy, sell, or hold?
Analysts covering Regeneron currently average a Buy rating: 19 buy, 11 hold and 0 sell, from 30 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for REGN?
The average price target of $756.82 implies 5.17% downside from the last price of $798.04.
What is the latest analyst rating on REGN?
On Aug 17, 2026, Leerink Partners maintained Regeneron at Market Perform with a price target of $824.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.